Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
- PMID: 9736575
- PMCID: PMC105845
- DOI: 10.1128/AAC.42.9.2425
Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
Abstract
Of a total of 147 erythromycin-resistant Streptococcus pneumoniae isolates, 64 (43.5%) were resistant to erythromycin, clindamycin, and streptogramin B (MLSB phenotype), 57 of which possessed the ermB gene. Eighty-two (55.8%) were resistant to erythromycin alone (M phenotype), 81 of which possessed the mefE gene. One was erythromycin and streptogramin B resistant but susceptible to clindamycin (MS phenotype) and possessed neither the erm gene nor the mefE gene.
Figures
References
-
- Ausubel F M, Brent R, Kingston R E, Moore D D, Seidman J G, Smith J A, Struhl K, editors. Current protocols in molecular biology, chapter 2, section 2.9.2. New York, N.Y: John Wiley & Sons, Inc.; 1997.
-
- Fernandez-Munoz R, Monro R E, Torres-Pinedo R, Vasquez D. Substrate- and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites. Eur J Biochem. 1971;23:185–193. - PubMed
-
- National Committee for Clinical Laboratory Standards. Approved standards M2-A6 and M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
